About Wells Bio
Wells Bio develops in vitro diagnostic tests from its research facilities in South Korea, serving healthcare providers across Europe, Americas, Africa and Asia. The company specializes in:
- Rapid diagnostic tests using ROSUS™ technology
- Molecular diagnostic solutions including careGENE™
- COVID-19 testing solutions
- Immunochromatography applications
Founded in 2013, Wells Bio maintains operations through Access Bio Inc. in the USA and Ethiopia while expanding its diagnostic solutions portfolio with CE and KFDA certifications.
Frequently asked questions
Wells Bio manufactures diagnostic products in the following categories:
- Rapid Diagnostic Tests
- careUS™ COVID-19 Antigen Home Test
- careUS™ Strep A Plus
- Molecular Diagnostic Tests
- careGENE™ STD-12 detection kit
- careGENE™ COVID-19 RT-PCR kit
- Diagnostic Equipment
- careSTART™ S1 Analyzer
- Biosensor systems
All products utilize immunochemical, biochemical, and molecular diagnostic technologies for disease diagnosis.
Wells Bio’s operations are built on these foundations:
| Category | Details |
|---|---|
| Core Technologies |
|
| Certifications |
|
| Technical Features |
|
Founded in 2013, the company continues to expand its technological capabilities.
Wells Bio operates across multiple regions:
- Headquarters
- Seoul, South Korea
- International Locations
- Access Bio, Inc. – USA
- Ethiopia facility
- Market Coverage
- Europe
- Americas
- South-East Asia
- Africa
- Middle East
The company maintains distribution networks across these regions to serve healthcare facilities and laboratories.
More details about Wells Bio
Wells Bio: A leading diagnostic technology company in Seoul
Wells Bio, established in 2013 in Seoul, South Korea, operates as a cosmetic lab and diagnostic technology developer. The company specializes in creating advanced in vitro diagnostic tests, combining immunochemical, biochemical, and molecular diagnostic technologies.
Advanced diagnostic solutions and technologies
At the core of Wells Bio’s operations is their proprietary ROSUS™ technology – a next-generation immunochromatography system that employs fluorescence molecules to enhance signal intensity and accuracy in diagnostic testing.
Product range and services
- Rapid diagnostic tests (RDTs)
- Biosensor development
- Molecular diagnostic testing
- careSTART™ S1 Analyzer systems
- careGENE™ detection kits
- careUS™ product line
Global reach from South Korea
Based in Seoul’s biotechnology hub, Wells Bio has expanded its operations across multiple continents. The company maintains a strong presence in:
- Europe
- Americas
- South-East Asia
- Africa
- Middle East
Quality assurance and certifications
Wells Bio maintains high standards through various international certifications, including:
- CE certification for European markets
- KFDA certification for Korean markets
Recent developments
The company has successfully launched several products in response to market needs, including the careUS™ COVID-19 Antigen Home Test and careGENE™ COVID-19 RT-PCR kit, demonstrating their ability to adapt to emerging healthcare challenges.
Company gallery
